Project Grant K99GM155595

Award Date 8/8/24
Completion Date 7/31/26
Dollars Obligated $125K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Cambridge, MA 02142, USA
Similar Awards
This Project Grant award of $380,495.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the mechanisms and factors that promote aberrant DNA repair at meiotic double-strand breaks, which can lead to the formation of de novo structural variants in the germline. The research program at the Regents of the University of Michigan will address how closely spaced double-strand...
This $400,000 Project Grant award from the National Human Genome Research Institute (NHGRI) under CFDA 93.172 "Human Genome Research" will support a research program at Brigham & Women's Hospital to develop advanced computational methods for accurately identifying and genotyping structural variants within large genetic biobank datasets. The key objectives of the work are to: 1) create haplotype-informed algorithms to improve detection sensitivity and genotyping accuracy for...
The National Institute of General Medical Sciences (NIGMS) awarded a $401,914 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Research Foundation For The State University Of New York (RF SUNY) for a 5-year research project beginning February 1, 2025. The project aims to elucidate the evolutionary, biomedical, and functional impact of genomic structural variations, including deletions, duplications, inversions, and translocations of large DNA...
The National Human Genome Research Institute (NHGRI) awarded a $457,920 Project Grant (CFDA #93.172 - Human Genome Research) to The Broad Institute, Inc. to develop a deep reinforcement learning framework for haplotype assembly. Haplotype assembly is critical for understanding human population genetics and disease, as it reconstructs the combination of alleles on maternally and paternally inherited chromosome copies. The Broad Institute, a renowned biomedical and genomic research organization,...
The National Institute of General Medical Sciences (NIGMS) awarded a $445,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Dana-Farber Cancer Institute, Inc. (Dfci) in Boston, Massachusetts. The grant, which runs from January 22, 2025 to December 31, 2029, supports research to elucidate the molecular mechanisms of DNA double-strand break repair by homologous recombination. The goal of this project is to define the processes that allow cells to...
This Project Grant award of $1,375,594.00 from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) supports the development of a novel platform called Helicase-Assisted Continuous Evolution (HACE) for performing multiplexed locus-specific hypermutation within the mammalian genome. The HACE system utilizes a nick-directed helicase fused to a deaminase domain to introduce continuous mutations in large genomic targets, directed by a Cas9 nickase and locus-specific...
The National Institute of General Medical Sciences (NIGMS) awarded a $822,500 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Trustees of Columbia University in the City of New York to study the mechanisms and genetic consequences of break-induced replication (BIR). The 5-year project aims to (1) determine how BIR is regulated at telomeres and transcriptionally active genomic regions, and (2) develop new experimental tools and techniques for studying BIR. The...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $993,446 Project Grant to the Sloan-Kettering Institute for Cancer Research. The 5-year grant, effective May 1, 2025, will support the development of statistical and machine learning approaches to decode the regulatory activity underlying disease variants, link variants to genes in relevant cell types, and identify disease-critical gene programs and genomic...
This $292,727 Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports a research project by The Broad Institute, Inc. to discover novel regulators of 3D genome organization. The project aims to leverage large-scale genomic datasets to predict and experimentally validate new trans-acting factors that regulate chromatin interactions and genome architecture. By applying deep neural network models to in silico genetic...
This federal Project Grant award of $616,786, awarded on June 1, 2025 by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research aimed at uncovering the evolutionary mechanisms shaping genetic variation and phenotypic diversity across human populations. The key focus areas of the research include: 1) exploring the effects of recessive deleterious alleles and associative overdominance on patterns of...

This Project Grant award of $125,000 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the factors that shape the formation of structural variants in the human genome. The research aims to use computational and experimental methods to investigate the role of imperfect sequence homology, or microhomology, in double-strand break repair processes that can lead to structural variants. Additionally, the research will analyze patterns of structural variants in human genomes to determine the effects of defects in double-strand break repair genes. The findings from this work are expected to provide greater insight into the cellular mechanisms underlying genomic integrity and their relevance to human health conditions. The award recipient, The Broad Institute, Inc., is a renowned biomedical research organization that will leverage its expertise in genomics, computational biology, and experimental methods to conduct this research project over the period of August 2024 to July 2026.

Generated 7/1/25, 2:42 AM